Subscribe To
Qatar cement market poised for remarkable growth, with projected valuation of us$ 1,550.9 million by 2032 | future market insights, inc.
The construction industry’s growth significantly influences the cement sector, as cement is a fundame...
October 17, 2023, 4:30 am
Jubilee metals group: exceptional early bird opportunity
Rarely an irrational market opens a fantastic rational opportunity. Jubilee Metals Group plc is significantly ...
October 17, 2023, 1:49 am
Pboc sets usd/ cny central rate at 7.1796 (vs. estimate at 7.3038)
The People's Bank of China set the onshore yuan (CNY) reference rate for the trading session ahead.USD/CNY is the onshore yuan. Its permitted to trade...
October 17, 2023, 1:15 am
Ecb’s lane emphasizes long road ahead before rate cuts
In an interview with Het Financieele Dagblad, ECB Chief Economist Philip Lane stressed the European Central Bank’s stance on the prevailing inflatio...
October 17, 2023, 1:03 am
Trade gas: impact of geopolitics and reserves on prices
Trade Gas: Impact of Geopolitics and Reserves on Prices The interplay between geopolitical tensions, weather fluctuations, and energy reserves can
October 16, 2023, 2:58 pm
Chargepoint forecast: what will chpt stock be worth in 5 years?
ChargePoint Holdings (NYSE: CHPT ) is growing rapidly, and its growth is likely to accelerate significantly ...
October 16, 2023, 2:35 pm
Latino entrepreneurs looking to small business administration for capital
The Biden administration has significantly expanded its loans to Latino-owned businesses, who face an u...
October 16, 2023, 1:44 pm
Pick on price weakness: leave room to add on further declines
Base metals prices have declined significantly since their highs in 2022, impacting the performance of ...
October 16, 2023, 1:15 pm
Mort: no real compelling case to buy
The VanEck Mortgage REIT Income ETF is difficult to justify in a portfolio due to high interest rates and a looming recession. The MORT ETF offers inv...
October 16, 2023, 12:25 pm
Gas trading in europe: impact of cooler temperatures
Gas Trading in Europe: Impact of Cooler Temperatures In the ever-evolving world of energy trading, the gas market is pivotal in ensuring a stable and ...
October 16, 2023, 9:13 am
Bwx: meaningful capital appreciation likely in 2024 and 2025
SPDR Bloomberg International Treasury Bond ETF owns investment-grade international treasury bonds with minimal credit risk. BWX has declined...
October 16, 2023, 5:56 am
Buy yang to profit from china's bursting bubble
Chinese stocks are expected to decline significantly due to geopolitical tensions with the USA, a burst...
October 16, 2023, 2:58 am
Pboc sets usd/ cny reference rate for today at 7.1798 (vs. estimate at 7.3121)
The People's Bank of China set the onshore yuan (CNY) reference rate for the trading session ahead.USD/CNY is the onshore yuan. Its permitted to trade...
October 16, 2023, 1:15 am
Netflix: headwinds, just how big?
Netflix's share price has been under pressure due to lagging expectations in cracking down on password sharing and generating advertising revenues. Th...
October 15, 2023, 11:54 pm
Enghouse systems: the transition to saas is promising
Enghouse Systems is a Canadian software and services company that specializes in customer engagement solutions and telecommunications software. EGHSF ...
October 15, 2023, 11:39 pm
Should you buy bitcoin while it’s below $30,000?
Looking out even 12 months from now, it’s possible that Bitcoin’s price will be significantly highe...
October 15, 2023, 10:29 am
Ultragenyx and mereo biopharma announce interim phase 2 data from phase 2/3 orbit study demonstrating setrusumab (ux143) significantly reduced fracture rates in patients with osteogenesis imperfecta (
Phase 2 data presented at ASBMR 2023 show treatment with setrusumab resulted in 67% reduction in annualized fracture rate associated with continuous a...
October 14, 2023, 8:30 pm
Ultragenyx and mereo biopharma announce interim phase 2 data from phase 2/3 orbit study demonstrating setrusumab (ux143) significantly reduced fracture rates in patients with osteogenesis imperfecta (
Phase 2 data presented at ASBMR 2023 show treatment with setrusumab resulted in 67% reduction in annualized fracture rate associated with continuous a...
October 14, 2023, 8:30 pm
Ultragenyx and mereo biopharma announce interim phase 2 data from phase 2/3 orbit study demonstrating setrusumab (ux143) significantly reduced fracture rates in patients with osteogenesis imperfecta (
Phase 2 data presented at ASBMR 2023 show treatment with setrusumab resulted in 67% reduction in annualized fracture rate associated with continuous a...
October 14, 2023, 8:30 pm
Ultragenyx and mereo biopharma announce interim phase 2 data from phase 2/3 orbit study demonstrating setrusumab (ux143) significantly reduced fracture rates in patients with osteogenesis imperfecta (
Phase 2 data presented at ASBMR 2023 show treatment with setrusumab resulted in 67% reduction in annualized fracture rate associated with continuous a...
October 14, 2023, 8:30 pm